← Back to patent-cliff list
CAS 2413011-17-1
[3-(4-Bromobenzoyl)-2-oxocyclohexyl]acetic acid
Codes: Bromfenac Sodium-037
Application context (from source-drug indications)
Inflammatory diseaseBromfenac SodiumPostoperative painBromfenac Sodium眼睛发炎Bromfenac Sodium眼睛疼痛Bromfenac SodiumDry eye syndromeBromfenac Sodium黄斑水肿Bromfenac Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Bromfenac Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Methyl 4-bromobenzoate→4-Bromobenzoic acid ethyl ester→Methyl 3-(2-methoxy-2-oxoethyl)-2-oxocyclohexane-1-carboxylate→Ethyl 3-(2-ethoxy-2-oxoethyl)-2-oxocyclohexane-1-carboxylate→[3-(4-Bromobenzoyl)-2-oxocyclohexyl]acetic acid→[1,3-Dibromo-3-(4-bromobenzoyl)-2-oxocyclohexyl]acetic acid→[3-(4-Bromobenzoyl)-1,3-dichloro-2-oxocyclohexyl]acetic acid→[2-Amino-3-(4-bromobenzoyl)phenyl]acetic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.